Impact of Intravascular Ultrasound-Guided Optimal Stent Expansion on 3-Year Hard Clinical Outcomes

Circ Cardiovasc Interv. 2021 Oct;14(10):e011124. doi: 10.1161/CIRCINTERVENTIONS.121.011124. Epub 2021 Oct 19.

Authors

Affiliations

¹ Severance Cardiovascular Hospital, Yonsei University College of Medicine, Seoul, Korea (Y.-J.L., S.-J.H., C.-M.A., J.-S.K., B.-K.K., Y.-G.K., D.C., Y.J., M.-K.H.).
² Nanjing First Hospital, Nanjing Medical University, China (J.-J.Z., J.K., T.P., X.G., Z.G., S.-L.C.).
³ Cardiovascular Research Foundation, New York, NY (G.S.M.).

^# Contributed equally.

PMID: 34665657
DOI: 10.1161/CIRCINTERVENTIONS.121.011124

Abstract

[Figure: see text].

Keywords: drug-eluting stents; follow-up studies; myocardial infarction; percutaneous coronary intervention; stents.

Publication types

Research Support, Non-U.S. Gov't

MeSH terms

Coronary Angiography
Coronary Artery Disease* / diagnostic imaging
Coronary Artery Disease* / therapy
Drug-Eluting Stents*
Humans
Percutaneous Coronary Intervention* / adverse effects
Stents
Treatment Outcome
Ultrasonography, Interventional